CoChat

Proceedings: Human Leukocyte Antigen Haplo-Homozygous Induced Pluripotent Stem Cell Haplobank Modeled After the California Population: Evaluating Matching in a Multiethnic and Admixed Population

Open access
Pappas, Derek James, Gourraud, Pierre-Antoine, Le Gall, Caroline, Laurent, Julie, Trounson, Alan, DeWitt, Natalie, Talib, Sohel · 2015 · Stem Cells Translational Medicine

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Summary The development of a California-based induced pluripotent stem cell (iPSC) bank based on human leukocyte antigen (HLA) haplotype matching represents a significant challenge and a valuable opportunity for the advancement of regenerative medicine. However, previously published models of iPSC banks have neither addressed the admixed nature of populations like that of California nor evaluated the benefit to the population as a whole. We developed a new model for evaluating an iPSC haplobank based on demographic and immunogenetic characteristics reflecting California. The model evaluates haplolines or cell lines from donors homozygous for a single HLA-A, HLA-B, HLA-DRB1 haplotype. We generated estimates of the percentage of the population matched under various combinations of haplolines derived from six ancestries (black/African American, American Indian, Asian/Pacific Islander, Hispanic, and white/not Hispanic) and data available from the U.S. Census Bureau, the California Institute for Regenerative Medicine, and the National Marrow Donor Program. The model included both cis (haplotype-level) and trans (genotype-level) matching between a modeled iPSC haplobank and the recipient population following resampling simulations. We showed that serving a majority (>50%) of a simulated California population through cis matching would require the creation, redundant storage, and maintenance of almost 207 different haplolines representing the top 60 most frequent haplotypes from each ancestry group. Allowances for trans matching reduced the haplobank to fewer than 141 haplolines found among the top 40 most frequent haplotypes. Finally, we showed that a model optimized, custom haplobank was able to serve a majority of the California population with fewer than 80 haplolines. Significance Induced pluripotent stem cell (iPSC) technology offers the promise of cellular therapies for a wide variety of diseases and injuries. Should these clinical trials be successful, it will be necessary to consider what it would take to deliver these novel treatments to the large numbers of patients who will need them. The use of allogeneic iPSC cell lines for derivation of grafts for transplantation has been considered; however, in order to avoid graft rejection by the allogeneic host, immunological compatibility between graft and host need to be considered. Creation of a haplobank of iPSC lines homozygous for a variety of HLA types, representative of different geographic populations and ethnic groups, could simplify HLA matching and provide matches for reasonable percentages of target populations and extend iPSC-derived therapies beyond the autologous setting. To that end, the rationale for the current study was that the genetic diversity of California's population might be a considerable advantage in establishing a representative “world bank” compared with banking from countries in which populations have more uniform ancestry.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5966/sctm.2015-0052

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 1

  1. T ommunit Uniting Researchers & Resources: he STEM CELLS Journal Online C y Uniting Researchers & Resources:The STEM CELLS Journal Online Community http://StemCellsPortal.com/content/2015-0052

Cited by

Metadata

Authors
Pappas, D. J., Gourraud, P.-A., Le Gall, C., Laurent, J., Trounson, A., DeWitt, N., & Talib, S.
Affiliations
  • Methodomics, Mortagne-sur-Sevre, France
  • University of California, San Francisco (US)
  • Institut Supérieur des Biotechnologies de Paris (FR)
  • California Institute for Regenerative Medicine (US)
Corresponding author
Gourraud, Pierre-Antoine
Venue
Stem Cells Translational Medicine
Published
2015-03-13
Volume
4
Issue
5
Pages
413-418
ISSN
  • 2157-6564 (ISSN-L)
  • 2157-6580
OpenAlex
W2097085702
Cited by
57
References
22
Citations by year
2025: 2 · 2024: 8 · 2023: 2 · 2022: 9 · 2021: 6 · 2020: 12 · 2019: 9 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 3
FWCI
1.30
Type
journal article
Language
en
Open access
Locations
  • Stem Cells Translational Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
California Institute for Regenerative Medicine
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Forensic and Genetic Research
Keywords
HLA haplotype matching, admixed populations, California population, ancestry groups, haplotype frequencies, graft rejection, immunological compatibility
MeSH terms
California, Cell Line, Ethnicity, Genetics, Population, Genotype, Haplotypes, Histocompatibility Testing, HLA Antigens, Homozygote, Humans, Tissue Donors, Induced Pluripotent Stem Cells, Stem Cell Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.